Ricevi le ultime notizie sulle azioni Cardio Diagnostics Hldgs con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di CDIO

Ultime notizie per

Cardio Diagnostics Hldgs

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc. - Warrant

News

Press Releases

Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO

Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

BIAF

CDIO

CSDX

INBS

SOBR

TRIB

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

AIM ImmunoTech

Alzamend Neuro

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptevo Therapeutics

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

enGene Holdings

Ensysce Biosciences

Galmed Pharmaceuticals Ltd. - Ordinary Shares

Galmed Pharmaceuticals

Genprex

HCW Biologics

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Mainz Biomed

Polyrizon

PharmaCyte Biotech

Sunshine Biopharma

SILO Pharma

Tharimmune

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Benchmark

Northland Capital Markets

Screenshot 2025-08-05 at 5.38.26 PM

Biotech

Health Care

Cardio Diagnostics&#39; AI-Powered Coronary Heart Disease Tests Get Medicare Reimbursement Pricing

Screenshot 2025-07-16 at 5.42.28 PM

Cardio Diagnostics And AGEPHA Pharma Team Up To Advance Inflammation-Driven Coronary Heart Disease Diagnosis And Treatment

Screenshot 2024-09-16 at 6.26.11 PM

General

Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics&#39; Heart Disease Tests

Screenshot 2024-05-23 at 10.15.30 PM

Interview

This Medtech Company Is Bringing &#34;Precision&#34; Medicine To Cardiovascular Diagnostics

Screenshot 2024-05-06 at 5.31.30 PM

New Study Shows Cardio Diagnostics&#39; (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually

Screenshot 2024-04-30 at 5.36.02 PM

MRNA

3 Trends In Healthcare Guided By AI And The Companies Behind The Innovation

Screenshot 2024-04-23 at 6.35.19 PM

As the Use of AI In Healthcare Grows, Cardio Diagnostic Is Using It In Quest to Help Prevent Cardiovascular Disease

Screenshot 2024-04-11 at 5.31.26 PM

Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests

Comments

Cardio Diagnostics Hldgs Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO